dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.
- Exoskeletons identified as priority application for sensor and neuromorphic tech
- Proprietary motion sensing enables real-time adaptive control and safety
- RRAM neuromorphic chips provide ultra-low-power edge processing
- Market opportunity extends beyond exoskeletons to $100B human-robot collaboration
- Acquisition of neuromorphic IP from The Technion completed, partnerships underway
dorsaVi’s Strategic Shift into Exoskeleton Intelligence
dorsaVi Ltd (ASX:DVL) is gearing up to become a key player in powered exoskeleton systems, a market forecast to exceed USD 2 billion by 2033. The company is leveraging its existing wearable motion sensor technology combined with its RRAM-based neuromorphic semiconductor program to provide the critical intelligence layer these systems require. This move represents a natural extension of dorsaVi’s sensor heritage rather than a departure from its core business.
Powered exoskeletons, wearable robotics that augment human strength and endurance, are rapidly transitioning from research labs to frontline applications in defence, healthcare, industrial safety, and aged care. The missing link in current systems is real-time intelligence that can safely interpret and respond to human movement, a gap dorsaVi aims to fill with its proprietary motion sensing technology.
Sensor Intelligence and Neuromorphic Edge Computing
dorsaVi’s wearable sensors capture high-fidelity biomechanical data, serving as the ‘digital nervous system’ that informs exoskeleton control systems how the wearer moves and where force is applied. This data enables adaptive gait control, joint tracking, and fatigue detection, essential for safety and performance. The company’s RRAM neuromorphic semiconductor program complements this by delivering ultra-low-power, brain-inspired edge processing that operates independently of cloud connectivity, critical for wearable, battery-powered devices.
This synergy between sensor and neuromorphic technologies was recently validated with a projected tenfold performance gain in speed and power efficiency, underscoring the platform’s suitability for exoskeleton and broader robotics applications. The firmware upgrade embedding on-sensor intelligence further reduces latency, paving the way for seamless integration of neuromorphic computing at the edge Sensor V6.5 firmware upgrade and RRAM-Neuromorphic Platform Delivering 10x Performance.
Three Application Pathways and Market Segments
dorsaVi is initially focusing on three high-value exoskeleton applications: sensor-driven intelligence layers for adaptive control, closed-loop human-in-the-loop robotic systems for precise operator feedback, and fatigue-aware robotics that predict injury risk and adjust assistance accordingly. These applications span rehabilitation, aged care, industrial safety, and defence sectors, each demanding real-time safety compliance and energy-efficient operation.
The exoskeleton market’s rapid growth is driven by increasing adoption in soldier augmentation, workplace injury prevention, mobility rehabilitation, and elderly assistance. dorsaVi’s fatigue-aware analytics address regulatory compliance needs in industrial environments, while its sensor intelligence enhances rehabilitation robotics’ adaptive capabilities.
Expanding Beyond Exoskeletons into a $100 Billion Robotics Ecosystem
The technology stack underpinning dorsaVi’s exoskeleton strategy, real-time human sensing, biomechanical analytics, and neuromorphic edge compute, has broad applicability across the human-robot collaboration landscape. This includes industrial collaborative robots (cobots), surgical and rehabilitation robotics, autonomous mobile robots in logistics, defence human-robot teaming, and agricultural field robotics.
Each of these sectors requires safe, adaptive interaction between humans and machines, with stringent safety compliance and low-latency processing. dorsaVi’s vertically integrated sensor and neuromorphic platform positions it to capture significant market share in these areas, collectively forecast to exceed USD 100 billion by 2030.
IP Acquisition and Strategic Partnerships in Israel
Strengthening its IP portfolio, dorsaVi has completed the acquisition of neuromorphic and in-memory processing intellectual property from The Technion, a leading research university. This complements its ongoing RRAM development at the 22-nm node with partners ITRI and NTU, adding circuit-level design depth for memristor-based logic critical to its ultra-edge computing strategy.
Following the acquisition, dorsaVi has initiated discussions with Israeli strategic partners and venture capital firms, tapping into a deep technology ecosystem renowned for semiconductor design and defence electronics. This collaboration aims to accelerate the commercialisation of dorsaVi’s neuromorphic and in-memory computing capabilities, reinforcing its position in advanced robotics and wearable systems.
Bottom Line?
dorsaVi’s pivot to exoskeleton intelligence leverages proven tech and strategic IP to pursue a rapidly growing $2 billion market, with broader robotics expansion poised to follow.
Questions in the middle?
- How quickly can dorsaVi convert its technology into commercial exoskeleton partnerships?
- What competitive advantages will dorsaVi’s neuromorphic RRAM platform deliver over incumbents?
- How will regulatory and safety standards shape adoption in defence and healthcare sectors?